Foreword |
|
v | |
Preface |
|
xv | |
|
|
xvii | |
|
|
1 | (110) |
|
1 Philosophical Aspects of Neuropsychiatry |
|
|
3 | (24) |
|
|
1.1 Development of Research Paradigms and Strategies in Psychiatry |
|
|
4 | (1) |
|
1.2 The Mind-Body Problem - Philosophy of Mind |
|
|
5 | (6) |
|
|
8 | (1) |
|
|
9 | (1) |
|
1.2.3 Identity Theory and its Problems |
|
|
9 | (2) |
|
|
11 | (1) |
|
|
11 | (1) |
|
1.3 The Conditions of Scientific Knowledge - Philosophy of Science |
|
|
11 | (1) |
|
1.4 Experimental Research - From Observation to Theory |
|
|
12 | (5) |
|
1.4.1 Hypotheses and Theory |
|
|
14 | (1) |
|
1.4.2 The "Epistemic Cycle" |
|
|
14 | (1) |
|
1.4.3 Top-Down Analysis - Reductionism? |
|
|
15 | (1) |
|
1.4.4 Bottom-Up Explanations - Holism? |
|
|
16 | (1) |
|
1.5 Theoretical (Neuro)psychiatry |
|
|
17 | (2) |
|
|
19 | (1) |
|
1.7 Perspectives - Towards a "Neurophilosophy" |
|
|
19 | (8) |
|
|
22 | (5) |
|
2 Neuropsychiatry - Subject, Concepts, Methods, and Computational Models |
|
|
27 | (54) |
|
|
|
|
27 | (1) |
|
2.2 Psychiatric Fundamentals of Neuropsychiatry |
|
|
27 | (6) |
|
|
27 | (1) |
|
|
28 | (1) |
|
2.2.2.1 Quantitative Psychopathology |
|
|
28 | (1) |
|
2.2.2.2 Theoretical Psychopathology |
|
|
29 | (1) |
|
2.2.3 Psychiatric Diagnoses |
|
|
30 | (1) |
|
2.2.3.1 Diagnostic Criteria |
|
|
30 | (1) |
|
2.2.4 Theoretical Psychiatry |
|
|
30 | (1) |
|
2.2.4.1 "Computational Neuropsychiatry" |
|
|
31 | (1) |
|
2.2.4.2 "Systems Neuropsychiatry" |
|
|
32 | (1) |
|
2.3 Neurobiological Fundamentals of Neuropsychiatry |
|
|
33 | (40) |
|
2.3.1 Basic Findings of (Neuro)biological Psychiatry |
|
|
33 | (1) |
|
2.3.1.1 Neuropsychopathology |
|
|
33 | (1) |
|
2.3.1.2 Neurobiological Methods |
|
|
34 | (1) |
|
2.3.1.3 Experimental Paradigms |
|
|
35 | (3) |
|
2.3.1.4 Structure and Function of the Brain |
|
|
38 | (2) |
|
2.3.1.5 Global Circuits and their Connectivities |
|
|
40 | (3) |
|
2.3.1.6 Local Networks of Neurons |
|
|
43 | (3) |
|
2.3.1.7 Prefrontal Network in Schizophrenia |
|
|
46 | (4) |
|
|
50 | (2) |
|
2.3.2.1 Electrical Signaling of the Neuron |
|
|
52 | (2) |
|
|
54 | (2) |
|
|
56 | (7) |
|
2.3.4 The Cell as a System of Interacting Molecules |
|
|
63 | (1) |
|
2.3.4.1 Intracellular Signal Cascades - From Receptor to Genome |
|
|
63 | (1) |
|
2.3.4.2 Modeling Signal Transduction Networks Relevant in Schizophrenia |
|
|
64 | (2) |
|
2.3.4.3 Genomics and Proteomics |
|
|
66 | (1) |
|
2.3.4.4 Gene Regulation - Circular Signaling Pathways |
|
|
67 | (2) |
|
2.3.4.5 Systems Biology of the Neuron |
|
|
69 | (1) |
|
2.3.5 The Brain as a Neurochemical Oscillator |
|
|
70 | (1) |
|
2.3.5.1 Neurochemical Interaction Matrix |
|
|
71 | (1) |
|
2.3.5.2 "Neurochemical Mobile" |
|
|
72 | (1) |
|
2.4 Conclusions and Perspectives |
|
|
73 | (8) |
|
|
76 | (5) |
|
3 Introduction to Systems Biology |
|
|
81 | (16) |
|
|
|
|
81 | (2) |
|
3.1.1 What is Systems Biology? |
|
|
81 | (1) |
|
3.1.2 Purpose of Modeling |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
83 | (3) |
|
|
83 | (1) |
|
|
83 | (1) |
|
|
83 | (1) |
|
3.2.1.3 Large-Scale Analyses |
|
|
84 | (1) |
|
3.2.1.4 Identification of Components |
|
|
84 | (1) |
|
|
84 | (1) |
|
3.2.2.1 Different Clustering Approaches |
|
|
85 | (1) |
|
3.2.2.2 Principal Component Analysis |
|
|
85 | (1) |
|
|
86 | (5) |
|
3.3.1 Differential Equations |
|
|
86 | (1) |
|
3.3.2 Stoichiometric Matrix |
|
|
86 | (1) |
|
|
87 | (1) |
|
|
88 | (1) |
|
3.3.5 Metabolic Control Analysis |
|
|
88 | (1) |
|
|
89 | (1) |
|
3.3.7 Parameter Estimation |
|
|
90 | (1) |
|
3.4 Results Gained from Systems Biology |
|
|
91 | (1) |
|
3.4.1 Just-in-Time Transcription |
|
|
91 | (1) |
|
3.5 Standard Formats, Databases, and Tools |
|
|
91 | (2) |
|
3.5.1 XML-Based Formats for ODE Models |
|
|
91 | (1) |
|
|
92 | (1) |
|
3.5.3 Tools for the Construction, Simulation, and Analysis of ODE Models |
|
|
93 | (1) |
|
3.6 Future Directions in Systems Biology |
|
|
93 | (4) |
|
|
94 | (3) |
|
4 Mind Over Molecule: Systems Biology for Neuroscience and Psychiatry |
|
|
97 | (14) |
|
|
4.1 Introduction: Mind and Molecule Meet |
|
|
97 | (1) |
|
4.2 First Steps: Modeling Excitable Cells |
|
|
98 | (3) |
|
4.3 Higher-Level Simulation |
|
|
101 | (3) |
|
|
104 | (1) |
|
4.5 Programs in the Brain? |
|
|
105 | (2) |
|
|
107 | (4) |
|
|
108 | (3) |
|
|
111 | (48) |
|
5 Neuropsychiatry, Psychopathology, and Nosology - Symptoms, Syndromes, and Endophenotypes |
|
|
113 | (16) |
|
|
|
|
113 | (1) |
|
5.2 Conceptual and Historical Introduction |
|
|
113 | (3) |
|
5.3 Finding the "Atomic Unit" in Psychopathology: Endophenotypes |
|
|
116 | (3) |
|
5.3.1 Susceptibility Genes |
|
|
117 | (1) |
|
5.3.2 Requirements for Endophenotypes |
|
|
118 | (1) |
|
5.3.3 Identified and Possible Endophenotypes |
|
|
118 | (1) |
|
5.3.4 Endophenotypes and the Role of Psychopathology |
|
|
119 | (1) |
|
5.4 Basic Methodological Problem: Time/Spatial Resolution |
|
|
119 | (3) |
|
5.4.1 An Example: Libet's Experiment |
|
|
120 | (1) |
|
5.4.2 The First Problem: The Estimation of W |
|
|
121 | (1) |
|
5.4.3 The Second Problem: The Explanatory Power in the Light of a Questionable Time Resolution |
|
|
121 | (1) |
|
5.5 Future New Diagnostic Schedules and Research |
|
|
122 | (1) |
|
5.6 On the Future Role of Psychopathology |
|
|
123 | (6) |
|
|
125 | (4) |
|
6 System Properties of Populations of Neurons in Cerebral Cortex |
|
|
129 | (16) |
|
|
|
129 | (2) |
|
6.2 Spatial Structure of Brain Waves |
|
|
131 | (2) |
|
6.3 Temporal Structure of the EEG/ECoG |
|
|
133 | (3) |
|
6.4 Behavioral Correlates in Spatio-Temporal Patterns of the EEG |
|
|
136 | (4) |
|
6.5 Synthesis of Two Levels of Function in the Cortical System |
|
|
140 | (1) |
|
6.6 Conclusions and Applications |
|
|
141 | (4) |
|
|
143 | (2) |
|
7 Dopamine and the Electrophysiology of Prefrontal Cortical Networks |
|
|
145 | (14) |
|
|
|
145 | (1) |
|
7.2 Electrophysiological Actions of DA in Prefrontal Cortical Circuits |
|
|
146 | (2) |
|
7.3 Changes in DA Modulation of Pyramidal Neurons during Adolescence |
|
|
148 | (1) |
|
7.4 Changes in DA Modulation of GABA Interneurons during Adolescence |
|
|
149 | (2) |
|
7.5 Abnormal Periadolescent Maturation of DA Actions in Developmental Animal Models of Schizophrenia |
|
|
151 | (2) |
|
7.6 Implications for Schizophrenia Pathophysiology and Novel Treatments |
|
|
153 | (6) |
|
|
154 | (5) |
|
Part Three Research in Molecular Psychiatry |
|
|
159 | (70) |
|
8 Nicotinic Cholinergic Signaling in the Human Brain - Systems Perspective |
|
|
161 | (28) |
|
|
|
|
161 | (1) |
|
8.2 Epidemiological Relevance of the Nicotinic Cholinergic System |
|
|
162 | (1) |
|
8.3 nAChrRs and the Cellular Effects of Nicotine |
|
|
163 | (6) |
|
8.4 Nicotine and Cognition |
|
|
169 | (2) |
|
|
171 | (2) |
|
8.6 Nicotine and Stress Response |
|
|
173 | (1) |
|
8.7 Variation in nAChrR Genes and Smoking |
|
|
174 | (4) |
|
|
178 | (1) |
|
8.9 Role of Systems Neuroscience |
|
|
179 | (10) |
|
|
181 | (8) |
|
9 Progress in Psychopharmacotherapy though Molecular Imaging |
|
|
189 | (18) |
|
|
|
|
9.1 Optimizing Psychopharmacotherapy through Molecular Imaging |
|
|
189 | (5) |
|
9.1.1 Techniques for Molecular Imaging in Living Brain |
|
|
189 | (1) |
|
9.1.1.1 Methodologic Background |
|
|
189 | (5) |
|
9.2 Characterization of Neurotransmitter Systems with Molecular Imaging |
|
|
194 | (2) |
|
|
196 | (3) |
|
9.4 Action of Psychopharmaceuticals in Schizophrenia |
|
|
199 | (8) |
|
|
203 | (4) |
|
10 The Marriage of Phenomics and Genetical Genomics: A Systems Approach to Complex Trait Analysis |
|
|
207 | (22) |
|
|
|
|
|
10.1 Introduction and Brief History of Genetical Genomics |
|
|
207 | (7) |
|
10.1.1 Characteristics of eQTLs |
|
|
209 | (1) |
|
10.1.2 Recent Developments |
|
|
210 | (3) |
|
10.1.3 Extension of Genetical Genomics to Include a Systems Approach to Phenomics |
|
|
213 | (1) |
|
10.2 Potential Pitfalls in Phenotype Selection and Current Technology |
|
|
214 | (4) |
|
10.3 General Strategy for Identifying Candidate Pathways |
|
|
218 | (4) |
|
10.4 Conclusions: Contributions of Genetical Genomic Phenomics to Systems Biology and Medicine |
|
|
222 | (7) |
|
|
224 | (5) |
|
Part Four Data Mining and Modeling |
|
|
229 | (118) |
|
11 From Communicational to Computational: Systems Modeling Approaches for Psychiatric Research |
|
|
231 | (12) |
|
|
|
231 | (2) |
|
11.2 Steps of the Modeling Process |
|
|
233 | (2) |
|
11.3 From Diagrams to Qualitiative Models through Petri Nets |
|
|
235 | (2) |
|
11.4 Petri Net Modeling of Apoptosis in Leukemic Cells and Neurons |
|
|
237 | (2) |
|
11.5 From Stoichiometric (Qualitative) to Kinetic (Quantitative) Genome-Scale Models |
|
|
239 | (1) |
|
11.6 From Diagrams Directly to Quantitative Canonical Models: The Concept Map Method |
|
|
239 | (2) |
|
|
241 | (2) |
|
|
242 | (1) |
|
12 Network Dynamics as an Interface between Modeling and Experiment in Systems Biology |
|
|
243 | (34) |
|
|
|
|
243 | (2) |
|
12.2 Aspects of Graph Theory |
|
|
245 | (6) |
|
12.3 A Network Perspective on Systems Biology |
|
|
251 | (9) |
|
12.3.1 Large-Scale Systems |
|
|
251 | (2) |
|
|
253 | (2) |
|
12.3.3 Metabolic Networks |
|
|
255 | (5) |
|
|
260 | (7) |
|
|
260 | (1) |
|
12.4.2 Binary Dynamics and Cellular Automata on Graphs |
|
|
261 | (6) |
|
12.5 Applicability in Psychiatry |
|
|
267 | (10) |
|
|
270 | (7) |
|
13 Some Useful Mathematical Tools to Transform Microarray Data into Interactive Molecular Networks |
|
|
277 | (24) |
|
|
|
|
|
277 | (1) |
|
|
278 | (1) |
|
13.3 Dimensionality Reduction |
|
|
279 | (5) |
|
13.3.1 Principal Components Analysis (PCA) |
|
|
279 | (2) |
|
13.3.2 Clustering Methods |
|
|
281 | (1) |
|
13.3.2.1 Partitional Clustering: k-Means |
|
|
282 | (1) |
|
13.3.2.2 Hierarchical Clustering: Bottom-Up and Top-Down Approaches |
|
|
282 | (2) |
|
13.4 Statistical Tests: ANOVA and the Naive Bayes Classifier |
|
|
284 | (2) |
|
|
286 | (8) |
|
13.5.1 Definition of a Bayesian Network |
|
|
286 | (2) |
|
13.5.2 Learning Bayesian Networks from Data |
|
|
288 | (3) |
|
13.5.3 Bayesian Networks and Microarrays |
|
|
291 | (3) |
|
13.6 Final Considerations |
|
|
294 | (7) |
|
|
295 | (6) |
|
14 Biochemical Networks in Psychiatric Disease |
|
|
301 | (20) |
|
|
|
|
Jeanette Hellgren Kotaleski |
|
|
|
|
301 | (1) |
|
14.2 The Example of Schizophrenia |
|
|
301 | (1) |
|
14.3 Looking for Nodes of Interaction |
|
|
302 | (1) |
|
14.4 Dopamine Signaling and DARPP-32 |
|
|
303 | (2) |
|
14.5 Physiological Role of DARPP-32 |
|
|
305 | (1) |
|
14.6 DARPP-32 in Psychiatric Disease |
|
|
306 | (2) |
|
14.7 Modeling Signaling Pathways with a Deterministic Model |
|
|
308 | (1) |
|
14.8 Biological Conclusions from the DARPP-32 Model |
|
|
309 | (1) |
|
|
310 | (1) |
|
14.10 PKA Activation: A Case Study |
|
|
311 | (5) |
|
|
311 | (1) |
|
14.10.2 Empirical Estimates of Rate Constants |
|
|
312 | (1) |
|
14.10.3 Model Validation against Steady-State Data |
|
|
313 | (1) |
|
14.10.4 Model Validation against Dynamic Data |
|
|
314 | (1) |
|
14.10.5 Deterministic versus Stochastic Algorithms |
|
|
314 | (2) |
|
|
316 | (5) |
|
|
316 | (5) |
|
15 Local Cortical Dynamics Related to Mental Illnesses |
|
|
321 | (20) |
|
|
|
|
|
321 | (1) |
|
15.2 A Recurrent Neural Network |
|
|
321 | (3) |
|
15.3 Concept of an Attractor Network |
|
|
324 | (1) |
|
|
325 | (3) |
|
|
328 | (6) |
|
|
328 | (4) |
|
|
332 | (2) |
|
|
334 | (7) |
|
|
335 | (6) |
|
|
341 | (6) |
|
|
16.1 Some General Remarks |
|
|
341 | (1) |
|
16.2 Pharmaceutical Discourse |
|
|
342 | (1) |
|
16.3 From Molecular to Cellular Networks |
|
|
342 | (1) |
|
|
343 | (4) |
|
|
344 | (3) |
Index |
|
347 | |